These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21386754)

  • 1. Cerivastatin, genetic variants, and the risk of rhabdomyolysis.
    Marciante KD; Durda JP; Heckbert SR; Lumley T; Rice K; McKnight B; Totah RA; Tamraz B; Kroetz DL; Fukushima H; Kaspera R; Bis JC; Glazer NL; Li G; Austin TR; Taylor KD; Rotter JI; Jaquish CE; Kwok PY; Tracy RP; Psaty BM
    Pharmacogenet Genomics; 2011 May; 21(5):280-8. PubMed ID: 21386754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis.
    Tamraz B; Fukushima H; Wolfe AR; Kaspera R; Totah RA; Floyd JS; Ma B; Chu C; Marciante KD; Heckbert SR; Psaty BM; Kroetz DL; Kwok PY
    Pharmacogenet Genomics; 2013 Jul; 23(7):355-64. PubMed ID: 23652407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic marker of statin-induced rhabdomyolysis].
    Chiba K; Morimoto K
    Yakugaku Zasshi; 2011 Feb; 131(2):247-53. PubMed ID: 21297370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin.
    Ishikawa C; Ozaki H; Nakajima T; Ishii T; Kanai S; Anjo S; Shirai K; Inoue I
    J Hum Genet; 2004; 49(10):582-585. PubMed ID: 15365880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis.
    Kaspera R; Naraharisetti SB; Tamraz B; Sahele T; Cheesman MJ; Kwok PY; Marciante K; Heckbert SR; Psaty BM; Totah RA
    Pharmacogenet Genomics; 2010 Oct; 20(10):619-29. PubMed ID: 20739906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel.
    Floyd JS; Kaspera R; Marciante KD; Weiss NS; Heckbert SR; Lumley T; Wiggins KL; Tamraz B; Kwok PY; Totah RA; Psaty BM
    Clin Pharmacol Ther; 2012 May; 91(5):896-904. PubMed ID: 22419147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cerivastatin withdrawal crisis: a "post-mortem" analysis.
    Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P
    Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.
    Psaty BM; Furberg CD; Ray WA; Weiss NS
    JAMA; 2004 Dec; 292(21):2622-31. PubMed ID: 15572720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
    ; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
    N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report.
    Kiage J; Venkatanarayan A; Roth M; Elam M
    J Clin Lipidol; 2022; 16(1):23-27. PubMed ID: 34887219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
    Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis.
    Ozaki H; Ishikawa CT; Ishii T; Toyoda A; Murano T; Miyashita Y; Shirai K
    J Clin Pharm Ther; 2005 Apr; 30(2):189-92. PubMed ID: 15811174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerivastatin-induced rhabdomyolysis: 11 case reports.
    Ravnan SL; Locke C; Yee WP; Haase K
    Pharmacotherapy; 2002 Apr; 22(4):533-7. PubMed ID: 11939690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerivastatin and gemfibrozil-associated rhabdomyolysis.
    Bruno-Joyce J; Dugas JM; MacCausland OE
    Ann Pharmacother; 2001 Sep; 35(9):1016-9. PubMed ID: 11573847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatal rhabdomyolysis caused by cerivastatin].
    Scheen AJ
    Rev Med Liege; 2001 Aug; 56(8):592-4. PubMed ID: 11584446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case reports of rhabdomyolysis associated with cerivastatin therapy.
    Simpson S
    Arch Intern Med; 2001 Nov; 161(21):2630-1. PubMed ID: 11718617
    [No Abstract]   [Full Text] [Related]  

  • 17. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
    Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
    Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP.
    Mykkänen AJH; Tarkiainen EK; Taskinen S; Neuvonen M; Paile-Hyvärinen M; Lilius TO; Tapaninen T; Klein K; Schwab M; Backman JT; Tornio A; Niemi M
    Clin Pharmacol Ther; 2024 Jun; 115(6):1428-1440. PubMed ID: 38493369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other reports of cerivastatin-induced rhabdomyolysis.
    Gabay M; Lodolce A
    Arch Intern Med; 2001 Nov; 161(21):2629. PubMed ID: 11718614
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis associated with cerivastatin: six cases within 3 months at one hospital.
    Lucas RA; Weathersby BB; Rocco VK; Pepper JM; Butler KL
    Pharmacotherapy; 2002 Jun; 22(6):771-4. PubMed ID: 12066968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.